KRAS and cancer: Upregulation of the MAPK signaling pathway is a common alteration in CRC and is generally mediated by activating mutations in KRAS, BRAF or NRAS. Alternatively, by upregulating EGF gene expression, cancer cells establish an autocrine feedback loop, abolishing their dependency on systemic EGF.